Inside Enhanced Caris Assure®: New RNA, DNA & Pharmacogenomic Insights

The enhanced Caris Assure® builds on its whole exome and matched white blood cell foundation, adding new clinically reportable RNA-based fusion detection, enhanced DNA detection and reporting, and expanded pharmacogenomic coverage to deliver a more complete, interpretable molecular picture from blood. Dr. Joseph Murray, Senior Medical Director of Thoracic Oncology at Caris Life Sciences, discusses what sets the test apart: https://bit.ly/4eYqHQO